DOSSIER · 13F Holders · Q2 2026
EGRX
EAGLE PHARMACEUTICALS IN
2 institutions still hold EAGLE PHARMACEUTICALS IN as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 269796108·2 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
2 institutions reported EGRX in Q2 2026. Stanley-Laman Group, Ltd. leads at 94.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.